Advertisement
Research Article

A Comparison of Cost Effectiveness Using Data from Randomized Trials or Actual Clinical Practice: Selective Cox-2 Inhibitors as an Example

  • Tjeerd-Pieter van Staa mail,

    Tjeerd.vanstaa@GPRD.com

    Affiliations: General Practice Research Database, London, United Kingdom, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands

    X
  • Hubert G. Leufkens,

    Affiliation: Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands

    X
  • Bill Zhang,

    Affiliation: General Practice Research Database, London, United Kingdom

    X
  • Liam Smeeth

    Affiliation: London School of Hygiene & Tropical Medicine, London, United Kingdom

    X
  • Published: December 08, 2009
  • DOI: 10.1371/journal.pmed.1000194

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.